Polar Capital Biotechnology R USD
WKNA1W70F
AssetklasseAktien
59,977€+0,02€
15.04.2026 20:47+ 0,03%
59,977€+0,02€
15.04.2026 20:47+ 0,03%
Eröffnung
59,325
Hoch
59,977
Tief
59,325
Umsatz
5.945,10
The objective of the Fund is to preserve capital and achieve longterm capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.The Fund is broadly diversified across countries, biotechnology sectors and by market-cap (a measure of company size).The Fund may invest in financial derivatives (complex instrumentsbased upon the value of underlying assets) for hedging, to reducerisk, to manage the Fund more efficiently, or to gain exposure tosecurities in a more efficient way.
Emittent
Fundrock Management Company (Ireland) Ltd
Benchmark
-
Fondsgröße in Mio.
3.056,41
Gesamtkostenquote (TER)
1,61 %
Tracking Difference
4,2488
Replikation
-
Fondswährung
USD
Domizil
IE
Fondsauflage
-
Ausschüttung
Ausschüttend
Ausschüttungsintervall
-
NAV
69,90
NAV Datum
13.4.2026